Ryou Ishikawa Selected Research

Ryou Ishikawa Research Topics

13	Neoplasms (Cancer) 03/2024 - 08/2017
5	Adenocarcinoma of Lung 12/2023 - 08/2017
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 08/2017
2	Carcinoma (Carcinomatosis) 01/2024 - 01/2021
2	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2023 - 02/2023
1	Ductal Carcinoma 01/2024
1	Pancreatic Ductal Carcinoma 01/2024
1	Margins of Excision 01/2024
1	Carcinogenesis 12/2023
1	Prostatic Neoplasms (Prostate Cancer) 10/2023
1	Neoplasm Metastasis (Metastasis) 09/2023
1	Glioma (Gliomas) 01/2023
1	Lung Diseases (Lung Disease) 04/2022
1	Adenocarcinoma 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Microsatellite Instability 01/2022
1	Pituitary ACTH Hypersecretion 04/2021
1	Acromegaly 04/2021
1	Glioblastoma (Glioblastoma Multiforme) 03/2020
1	Lymphatic Metastasis 08/2017
1	Villous Adenoma 07/2016

3	xylometazoline (stas)IBA 01/2021 - 08/2017
2	CateninsIBA 12/2023 - 01/2021
2	Prorenin ReceptorIBA 12/2023 - 01/2023
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 03/2024
1	Protein Isoforms (Isoforms)IBA 09/2023
1	SteroidsIBA 04/2022
1	Prednisolone (Predate)FDA LinkGeneric 04/2022
1	TinIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Insulin (Novolin)FDA Link 04/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2021
1	pasireotideIBA 04/2021
1	Growth Hormone (Somatotropin)IBA 04/2021
1	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2021
1	GP 4 (GP4)IBA 01/2021
1	Uridine Monophosphate (UMP)IBA 12/2020
1	Cyclin-Dependent Kinase Inhibitor p16IBA 03/2020
1	VimentinIBA 03/2020
1	Glial Fibrillary Acidic ProteinIBA 03/2020
1	Keratins (Keratin)IBA 03/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2020
1	Anaplastic Lymphoma KinaseIBA 01/2019
1	MucinsIBA 07/2016

5	Therapeutics 01/2024 - 03/2020
2	Prostatectomy (Retropubic Prostatectomy) 10/2023 - 02/2023
1	Neoadjuvant Therapy 01/2024
1	Aftercare (After-Treatment) 04/2022
1	Drug Therapy (Chemotherapy) 04/2021